Glenmark Pharmaceuticals informs about Board meeting

17 Oct 2014 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on October 30, 2014, to consider and approve the Company’s Unaudited Financial Statements for the Second Quarter/Half year ended September 30, 2014 (Q2). Further, as per the ‘Code of Conduct for Prevention of Insider Trading' of the Company, the trading window shall remain closed for Directors and other designated employees of the Company from October 17, 2014 to October 31, 2014 for the purpose of approval of Unaudited Financial Results for the Second Quarter/Half year ended September 30, 2014.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1985.90 -15.15 (-0.76%)
28-Jan-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1611.90
Dr. Reddys Lab 1224.10
Cipla 1315.80
Zydus Lifesciences 889.30
Lupin 2126.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×